Under this scenario, we suggest that LPA may also promote the expression of CD36 in NPC hepatocytes through the PPAR-γ pathway (similar to what was discussed in obesity), promoting lysosome dysfunction. The gene discussed is CD36; the disease is obesity due to melanocortin 4 receptor deficiency.